-
Mashup Score: 8Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas - 12 hour(s) ago
For more than 70 years, glucocorticoids have been known to have clinical activity against lymphoid but not myeloid malignancies. Choi et al. resolve this conundrum by demonstrating that glucocorticoids kill lymphomas by inhibiting BCR signaling. These mechanistic insights enable rational combination of glucocorticoids with other targeted agents in anti-lymphoma regimens.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 43Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis - 3 day(s) ago
Key Points. CAR-T cell therapy demonstrates superior efficacy to bispecific antibody in DLBCL treatment, with higher complete response rates.CAR-T cell the
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Analysis of @DrRaulCordoba FOLLOWERS - 4 day(s) ago
Mis seguidores viven en España(45%),Estados Unidos(22%),UK.(6%) y más tweepsmap.com/!DrRaulCordoba
Source: fedica.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 40Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis - 6 day(s) ago
Key Points. CAR-T cell therapy demonstrates superior efficacy to bispecific antibody in DLBCL treatment, with higher complete response rates.CAR-T cell the
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9
Chimeric Antigen Receptor-T (CAR-T) cell infusion is a rapidly evolving antitumor therapy; however, cardiovascular (CV) complications, likely associated with cytokine release syndrome (CRS) and systemic inflammation, have been reported to occur. The CARdio-Tox …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1
Un estudio prospectivo describe alteraciones ecocardiográficas tempranas en pacientes adultos con cánceres hematológicos tratados con esta modalidad terapéutica
Source: www.immedicohospitalario.esCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1La participación de pacientes con cáncer en ensayos clínicos se mejora la supervivencia - 7 day(s) ago
Los pacientes en estudios de fase 3 o aquellos patrocinados por grandes compañías farmacéuticas parecen tener un mayor beneficio clínico
Source: www.immedicohospitalario.esCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 38
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China; Tianjin Institutes of Health Science, Tianjin 301600 State Key
Source: haematologica.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 9Impulso a los ‘jóvenes hematólogos’ - 9 day(s) ago
Las áreas de actuación de ‘jóvenes hematólogos’ se centran en la formación, innovación y comunicación con el paciente
Source: elmedicointeractivo.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 26How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemia - 9 day(s) ago
Using 4 illustrative cases, Treon and colleagues discuss their approach to therapy in patients with Waldenström macroglobulinemia (WM) based on genomic pro
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
#Hematology Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive #lymphomas #lymsm https://t.co/PtVaMHrXvA